Patients with systemic lupus erythematosus (SLE) frequently present low levels of vitamin D. However, studies that have evaluated its association with disease activity have generated contradictory results.
Methods
A cross-sectional study was carried out on patients diagnosed with SLE in two hospitals in Manizales, Colombia. Disease activity was evaluated by the SLE disease activity index 2000 (SLEDAI-2K) and serum concentration of 25-hydroxyvitamin D (25(OH)D) was measured by chemiluminescence. The correlation analysis was accomplished with the Spearman correlation coefficient.
Results
The study included 51 patients. The median SLEDAI-2K score was 8 points. The mean serum level of 25(OH)D was 24.5 ng/ml. Of the participants, 37.3% had vitamin D insufficiency and 35.3% had deficiency. An inverse correlation was found between the levels of the 25(OH)D and the SLEDAI-2K score (r = –0.578, p < 0.001), being greater in late-onset lupus, with absence of polyautoimmunity and in patients using glucocorticoids.
Conclusions
Low levels of vitamin D are frequent in SLE, presenting an inverse correlation with the disease activity. This is influenced by the use of glucocorticoids, the presence of late-onset lupus and the absence of polyautoimmunity.
AnayaJMRestrepo-JimenezPRamirez-SantanaC.The autoimmune ecology: an update. Curr Opin Rheumatol2018;
30: 350–360.
3.
CantornaMT.Why do T cells express the vitamin D receptor?Ann N Y Acad Sci2011;
1217: 77–82.
4.
KongsbakMLevringTBGeislerCvon EssenMR.The vitamin D receptor and T cell function. Front Immunol2013;
4: 148.
5.
DanielCSartoryNAZahnNRadekeHHSteinJM.Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther2008;
324: 23–33.
6.
MoraJRIwataMvon AndrianUH.Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol2008;
8: 685–698.
7.
ShoenfeldYGiacomelliRAzrielantSBerardicurtiOReynoldsJABruceIN.Vitamin D and systemic lupus erythematosus – the hype and the hope. Autoimmun Rev2018;
17: 19–23.
8.
MokCC.Vitamin D and systemic lupus erythematosus: an update. Expert Rev Clin Immunol2013;
9: 453–463.
9.
YapKSMorandEF.Vitamin D and systemic lupus erythematosus: continued evolution. Int J Rheum Dis2015;
18: 242–249.
10.
YapKSNorthcottMHoiABMorandEFNikpourM.Association of low vitamin D with high disease activity in an Australian systemic lupus erythematosus cohort. Lupus Sci Med2015;
2: e000064.
11.
MokCCBirminghamDJLeungHWHebertLASongHRovinBH.Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis. Rheumatology (Oxford)2012;
51: 644–652.
12.
BonakdarZSJahanshahifarLJahanshahifarFGholamrezaeiA.Vitamin D deficiency and its association with disease activity in new cases of systemic lupus erythematosus. Lupus2011;
20: 1155–1160.
13.
SoutoMCoelhoAGuoC, et al.
Vitamin D insufficiency in Brazilian patients with SLE: prevalence, associated factors, and relationship with activity. Lupus2011;
20: 1019–1026.
14.
Garcia-CarrascoMMendoza-PintoCEtchegaray-MoralesI, et al.
Vitamin D insufficiency and deficiency in Mexican patients with systemic lupus erythematosus: prevalence and relationship with disease activity. Reumatol Clin2017;
13: 97–101.
15.
Ruiz-IrastorzaGEgurbideMVOlivaresNMartinez-BerriotxoaAAguirreC.Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology (Oxford)2008;
47: 920–923.
16.
TolozaSMColeDEGladmanDDIbanezDUrowitzMB.Vitamin D insufficiency in a large female SLE cohort. Lupus2010;
19: 13–19.
17.
SimioniJAHeimovskiFSkareTL.On lupus, vitamin D and leukopenia. Rev Bras Reumatol Engl Ed2016;
56: 206–211.
18.
Lopez-RoblesCRios-FernandezRCallejas-RubioJLOrtego-CentenoN.Vitamin D deficiency in a cohort of patients with systemic lupus erythematous from the South of Spain. Lupus2011;
20: 330–331.
19.
Granado LorencioFBlanco-NavarroIPerez-SacristanB.Critical evaluation of assays for vitamin D status. Curr Opin Clin Nutr Metab Care2013;
16: 734–740.
20.
BinkleyNCarterGD.Toward clarity in clinical vitamin D status assessment: 25(OH)D assay standardization. Endocrinol Metab Clin North Am2017;
46: 885–899.
21.
HolickMFBinkleyNCBischoff-FerrariHA, et al.
Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab2011;
96: 1911–1930.
22.
HolickMF.Vitamin D deficiency. N Engl J Med2007;
357: 266–281.
CastrejonITaniCJollyMHuangAMoscaM.Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care. Clin Exp Rheumatol2014;
32: S-85–95.
25.
MikdashiJNivedO.Measuring disease activity in adults with systemic lupus erythematosus: the challenges of administrative burden and responsiveness to patient concerns in clinical research. Arthritis Res Ther2015;
17: 183.
26.
AbrahamowiczMFortinPRdu BergerRNayakVNevilleCLiangMH.The relationship between disease activity and expert physician’s decision to start major treatment in active systemic lupus erythematosus: a decision aid for development of entry criteria for clinical trials.J Rheumatol1998;
25: 277–284.
27.
KamenDLCooperGSBoualiHShaftmanSRHollisBWGilkesonGS.Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev2006;
5: 114–117.
28.
MokCCBirminghamDJHoLYHebertLASongHRovinBH.Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q. Lupus2012;
21: 36–42.
29.
HamzaRTAwwadKSAliMKHamedAI.Reduced serum concentrations of 25-hydroxy vitamin D in Egyptian patients with systemic lupus erythematosus: relation to disease activity. Med Sci Monit2011;
17: Cr711–718.
30.
SahebariMNabaviNSalehiM.Correlation between serum 25(OH)D values and lupus disease activity: an original article and a systematic review with meta-analysis focusing on serum VitD confounders. Lupus2014;
23: 1164–1177.
31.
GuanSYCaiHYWangP, et al.
Association between circulating 25-hydroxyvitamin D and systemic lupus erythematosus: a systematic review and meta-analysis. Int J Rheum Dis2019;
22: 1803–1813.
32.
HuismanAMWhiteKPAlgraA, et al.
Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol2001;
28: 2535–2539.
33.
EloiMHorvathDVOrtegaJC, et al.
25-Hydroxivitamin D serum concentration, not free and bioavailable vitamin D, is associated with disease activity in systemic lupus erythematosus patients. PLoS One2017;
12: e0170323.
34.
Pons-EstelBACatoggioLJCardielMH, et al.
The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among ‘Hispanics’. Medicine (Baltimore)2004;
83: 1–17.
35.
CerveraRKhamashtaMAFontJ, et al.
Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore)1993;
72: 113–124.
BirminghamDJHebertLASongH, et al.
Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans. Lupus2012;
21: 855–864.
EzzatYSayedSGaberWMoheyAMKassemTW.25-Hydroxy vitamin D levels and its relation to disease activity and cardiovascular risk factors in women with systemic lupus erythematosus. The Egyptian Rheumatologist2011;
33: 195–201.
41.
Schmidt-GaykHGrawunderCTschopeW, et al.
25-Hydroxy-vitamin-D in nephrotic syndrome. Lancet1977;
2: 105–108.
42.
BarragryJMFranceMWCarterND, et al.
Vitamin-D metabolism in nephrotic syndrome. Lancet1977;
2: 629–632.
43.
Ruiz-IrastorzaGRamos-CasalsMBrito-ZeronPKhamashtaMA.Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis2010;
69: 20–28.
